Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
JL1 Expression in B-cell ALL
NCT04554381Phase 1Unknown
- Sponsor
- Assiut University
- Start
- Oct 2020
- Primary completion
- Oct 2023
01
Overview
Phase 1 trial (2 arms), sponsored by Assiut University. Primary endpoint: Evaluation and assessment of JL1 expression in B-cell Acute Lymphoblastic Leukemia. Status: unknown.
Beyond the preview
Go deeper on NCT04554381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04554381.